KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 118 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.60 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $432,000 | -30.0% | 22,537 | -78.1% | 0.02% | -40.0% |
Q2 2019 | $617,000 | +634.5% | 102,937 | +613.9% | 0.04% | +600.0% |
Q1 2019 | $84,000 | -79.6% | 14,418 | -67.1% | 0.01% | -80.8% |
Q4 2018 | $411,000 | -30.7% | 43,818 | +25.6% | 0.03% | -3.7% |
Q3 2018 | $593,000 | -67.4% | 34,874 | -67.4% | 0.03% | -63.5% |
Q2 2018 | $1,819,000 | +818.7% | 107,119 | +623.0% | 0.07% | +825.0% |
Q1 2018 | $198,000 | -37.1% | 14,816 | -55.0% | 0.01% | -42.9% |
Q4 2017 | $315,000 | +8.2% | 32,916 | +24.0% | 0.01% | -6.7% |
Q3 2017 | $291,000 | -51.4% | 26,552 | -60.5% | 0.02% | -44.4% |
Q1 2016 | $599,000 | -41.2% | 67,170 | -12.7% | 0.03% | -43.8% |
Q4 2015 | $1,019,000 | -28.9% | 76,950 | -43.5% | 0.05% | -9.4% |
Q3 2015 | $1,433,000 | +184.9% | 136,109 | +727.1% | 0.05% | +211.8% |
Q1 2015 | $503,000 | +6.8% | 16,457 | +7.8% | 0.02% | -32.0% |
Q1 2014 | $471,000 | – | 15,270 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |